XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Note O - Segment and Geographic Data | 12 Months Ended
--- | ---
Dec. 31, 2017
Notes to Financial Statements |
Product Sales and Significant Customers and Vendors Disclosure [Text Block] | NOTE O — SEGMENT AND GEOGRAPHIC DATA We conduct our business through two reportable segments: dental and medical. These segments offer different products and services to different customer base. The following tables present information about our reportable and operating segments:
Sales |  | Years ended |
Net Sales: |  | 2017 |  |  | 2016 |
Dental |  | $ | 11,279,886 |  |  | $ | 10,460,752 |
Medical |  |  | 2,000 |  |  |  | 21,253 |
Total |  | $ | 11,281,886 |  |  | $ | 10,482,005 |
Operating Income (Loss): |  | 2017 |  |  | 2016 |
Dental |  | $ | 3,127,570 |  |  | $ | 2,087,002 |
Medical |  |  | ( 2,389,145 | ) |  |  | ( 3,265,602 | )
Corporate |  |  | (5,972,743 | ) |  |  | ( 5,335,360 | )
Total |  | $ | ( 5,234,318 | ) |  | $ | ( 6,513,960 | )
Depreciation and Amortization: |  | 2017 |  |  | 2016 |
Dental |  | $ | 17,305 |  |  | $ | 17,619 |
Medical |  |  | 26,950 |  |  |  | 62,720 |
Other |  |  | 528,895 |  |  |  | 82,586 |
Corporate |  | $ | 573,150 |  |  | $ | 162,925 |
Total |  |  |  |  |  |  |  |
Income before taxes and equity in earnings of affiliates: |  | 2017 |  |  | 2016 |
Dental |  | $ | 3,136,167 |  |  | $ | 2,097,652 |
Medical |  |  | ( 2,391,082 | ) |  |  | ( 3,219,497 | )
Corporate |  |  | ( 5,975,035 | ) |  |  | ( 5,395,918 | )
Total |  | $ | ( 5,229,950 | ) |  | $ | ( 6,517,763 | )
Total Assets: |  | 2017 |  |  | 2016 |
Dental |  | $ | 10,255,144 |  |  | $ | 10,472,879 |
Medical |  |  | 655,513 |  |  |  | 913,840 |
Corporate |  |  | 4,718,130 |  |  |  | ( 2,794,921 | )
Total |  | $ | 15,628,787 |  |  | $ | 14,181,640 |
The following table presents information about our operations by geographic area as December 31, 2017 and 2017. Net sales by geographic area are based on the respective locations of our subsidiaries
|  | 2017 |  |  | 2016 |
|  | Dental |
Total Product Sales |  |  |  |  |  |  |  |
Domestic-US and Canada |  | $ | 5,339,709 |  |  | $ | 3,331,308 |
International -Rest of the World |  |  | 3,869,177 |  |  |  | 3,703,844 |
International -China |  |  | 2,071,000 |  |  |  | 3,425,600 |
Total |  | $ | 11,279,886 |  |  | $ | 10,460,752 |
Total Product Sales |  | Medical |
Domestic-US and Canada |  | $ | - |  |  | $ | - |
International - Rest of the World |  |  | 2,000 |  |  |  | 21,253 |
Total |  | $ | 2,000 |  |  | $ | 21,253 |
|  | Total |
Domestic-US and Canada |  | $ | 5,339,709 |  |  | $ | 3,352,561 |
International -Rest of the World |  |  | 3,871,177 |  |  |  | 3,703,844 |
International -China |  |  | 2,071,000 |  |  |  | 3,425,600 |
Total |  | $ | 11,281,886 |  |  | $ | 10,482,005 |

X
- Definition Entire disclosure of product sales and significant customers and vendors. + References No definition available. + Details
Name: | mlss_ProductSalesAndSignificantCustomersAndVendorsDisclosureTextBlock
Namespace Prefix: | mlss_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration